HeMemics Biotechnologies
John L. Warden, Jr. is the Co-Founder & CEO at HeMemics Biotechnologies. John has entrepreneurial and executive roles in 5 start-up companies to date, returning more than $75M in net profits to investors. He has successful business development experience with Biovista, a drug development services provider to major pharmaceutical companies, significant impact building markets for technology products, and developed, engineered, and constructed the proprietary software and hardware for the HEMEMICS chip and the reader device.
This person is not in any offices
HeMemics Biotechnologies
The HeMemics platform empowers healthcare providers to rapidly identify infectious disease pathogens in 60 seconds or less and generate real-time alerts to an outbreak.